nitrates has been researched along with alprostadil in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alexander, K; Bode-Böger, SM; Böger, RH; Creutzig, A; Frölich, JC; Thiele, W | 1 |
Allen, BS; Halldorsson, A; Ilbawi, M; Kronon, MT; Rahman, S; Wang, T | 1 |
Manecke, RG; Mulhall, JP | 1 |
Crowley, T; Gingell, C; Levy, A | 1 |
Chang, W; Hsiao, G; Lee, C; Lee, LW; Lin, CH; Sheu, JR; Su, CH | 1 |
Brovkovych, V; Huk, I; Malinski, T; Nanobashvili, J; Neumayer, C; Patton, S; Polterauer, P; Prager, M | 1 |
Traber, DL | 1 |
2 review(s) available for nitrates and alprostadil
Article | Year |
---|---|
Medical treatment of erectile dysfunction.
Topics: Adrenergic alpha-Antagonists; Aged; Alprostadil; Clinical Trials as Topic; Dopamine Agonists; Drug Interactions; Erectile Dysfunction; Hemodynamics; Humans; Male; Nitrates; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 1999 |
Non-surgical management of erectile dysfunction.
Topics: Administration, Topical; Alprostadil; Erectile Dysfunction; Humans; Male; Middle Aged; Nitrates; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Psychotherapy; Purines; Sildenafil Citrate; Sulfones; Testosterone; Vacuum; Vasodilator Agents | 2000 |
1 trial(s) available for nitrates and alprostadil
Article | Year |
---|---|
Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.
Topics: Aged; Aged, 80 and over; Alprostadil; Arginine; Arterial Occlusive Diseases; Blood Flow Velocity; Chronic Disease; Cyclic GMP; Double-Blind Method; Exercise Test; Female; Femoral Artery; Follow-Up Studies; Humans; Infusions, Intravenous; Intermittent Claudication; Leg; Male; Middle Aged; Nitrates; Nitric Oxide; Peripheral Vascular Diseases; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vasodilation; Vasodilator Agents | 1998 |
4 other study(ies) available for nitrates and alprostadil
Article | Year |
---|---|
L-arginine, prostaglandin, and white cell filtration equally improve myocardial protection in stressed neonatal hearts.
Topics: Alprostadil; Animals; Animals, Newborn; Arginine; Blood Pressure; Cardiac Volume; Cardioplegic Solutions; Cardiopulmonary Bypass; Coronary Vessels; Diastole; Free Radicals; Heart; Hypoxia; Leukapheresis; Leukocytes; Nitrates; Nitric Oxide; Oxidants; Peroxidase; Stress, Physiological; Stroke Volume; Swine; Systole; Vascular Resistance; Vasodilator Agents | 1999 |
Antiplatelet activity of Staphylococcus aureus lipoteichoic acid is mediated through a cyclic AMP pathway.
Topics: Alprostadil; Blood Platelets; Blood Proteins; Calcium Signaling; Collagen; Cyclic AMP; Cyclic GMP; Cytokines; Enzyme Induction; Gram-Positive Bacteria; Humans; Lipopolysaccharides; Molecular Weight; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroglycerin; Phorbol 12,13-Dibutyrate; Phosphorylation; Platelet Aggregation Inhibitors; Protein Kinase C; Protein Processing, Post-Translational; Second Messenger Systems; Shock, Septic; Staphylococcus aureus; Teichoic Acids | 2000 |
Prostaglandin E1 reduces ischemia/reperfusion injury by normalizing nitric oxide and superoxide release.
Topics: Acetylcholine; Alprostadil; Animals; Drug Evaluation, Preclinical; Hindlimb; Ischemia; Male; Muscle, Skeletal; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rabbits; Reperfusion Injury; Superoxides; Vasoconstriction | 2000 |
Nitric oxide synthase and tissue injury.
Topics: Alprostadil; Animals; Arginine; Burns; Enzyme Inhibitors; Humans; Ischemia; Luminescent Measurements; Models, Biological; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Oxidative Stress; Reperfusion Injury; Sepsis; Shock; Superoxides; Tyrosine | 2000 |